The Duke Comprehensive Parkinson’s Disease and Movement Disorders Clinic conducts a variety of clinical trials. Leading clinical trials is an important part of our mission to continually seek out better treatments and cures for those affected by movement disorders. Trials for the following conditions are currently available. If you believe you have one of these conditions and would like to participate, click on the links below to answer brief screening questions and express your interest in participating.
- Parkinson's Disease - This Neuraly Rho trial is testing a potential disease-modifying medication for early stage Parkinson disease. Take this short survey to see if you are eligible to participate.
- SCA 1 and 2 - The Duke Movement Disorders Clinic and Biohaven Pharmaceuticals are conducting a clinical trial for a medication for some inherited (genetic) forms of spinocerebellar ataxia (SCA), specifically SCA1 and 2. Take this short survey to see if you are eligible to participate.
- Writer's Cramp Dystonia - This clinical trial is testing the use of non-invasive brain stimulation to improve symptoms of writer's cramp dystonia. Take this short survey to see if you are eligible to participate.